KTE-C19: Preliminary Ph I ZUMA-3 and ZUMA-4 data

Preliminary data from 11 evaluable patients with relapsed or refractory ALL in the Phase I portions of the open-label, U.S. Phase I/II ZUMA-3 and ZUMA-4 trials showed that a single IV infusion of 2x1...